GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » SenesTech Inc (NAS:SNES) » Definitions » Altman Z-Score

SNES (SenesTech) Altman Z-Score : -43.75 (As of Dec. 12, 2024)


View and export this data going back to 2016. Start your Free Trial

What is SenesTech Altman Z-Score?

The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.

Warning Sign:

Altman Z-score of -43.94 is in distress zone. This implies bankruptcy possibility in the next two years.

SenesTech has a Altman Z-Score of -43.75, indicating it is in Distress Zones. This implies bankrupcy possibility in the next two years.

The zones of discrimination were as such:

When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.

The historical rank and industry rank for SenesTech's Altman Z-Score or its related term are showing as below:

SNES' s Altman Z-Score Range Over the Past 10 Years
Min: -51.56   Med: -19.8   Max: 28.72
Current: -43.94

During the past 10 years, SenesTech's highest Altman Z-Score was 28.72. The lowest was -51.56. And the median was -19.80.


SenesTech Altman Z-Score Historical Data

The historical data trend for SenesTech's Altman Z-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SenesTech Altman Z-Score Chart

SenesTech Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Altman Z-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -29.19 -25.26 -10.13 -27.94 -23.14

SenesTech Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Altman Z-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -51.56 -23.14 -34.61 -48.89 -44.11

Competitive Comparison of SenesTech's Altman Z-Score

For the Specialty Chemicals subindustry, SenesTech's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SenesTech's Altman Z-Score Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, SenesTech's Altman Z-Score distribution charts can be found below:

* The bar in red indicates where SenesTech's Altman Z-Score falls into.



SenesTech Altman Z-Score Calculation

Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

SenesTech's Altman Z-Score for today is calculated with this formula:

Z=1.2*X1+1.4*X2+3.3*X3+0.6*X4+1.0*X5
=1.2*0.7516+1.4*-30.3084+3.3*-1.4931+0.6*3.8872+1.0*0.3711
=-43.75

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.

Trailing Twelve Months (TTM) ended in Sep. 2024:
Total Assets was $4.45 Mil.
Total Current Assets was $3.97 Mil.
Total Current Liabilities was $0.63 Mil.
Retained Earnings was $-134.84 Mil.
Pre-Tax Income was -1.513 + -1.584 + -1.832 + -1.733 = $-6.66 Mil.
Interest Expense was -0.006 + -0.005 + -0.004 + -0.004 = $-0.02 Mil.
Revenue was 0.482 + 0.459 + 0.415 + 0.295 = $1.65 Mil.
Market Cap (Today) was $3.10 Mil.
Total Liabilities was $0.80 Mil.

* Note that for stock reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data.

X1=Working Capital/Total Assets
=(Total Current Assets - Total Current Liabilities)/Total Assets
=(3.972 - 0.628)/4.449
=0.7516

X2=Retained Earnings/Total Assets
=-134.842/4.449
=-30.3084

X3=Earnings Before Interest and Taxes/Total Assets
=(Pre-Tax Income - Interest Expense)/Total Assets
=(-6.662 - -0.019)/4.449
=-1.4931

X4=Market Value Equity/Book Value of Total Liabilities
=Market Cap/Total Liabilities
=3.102/0.798
=3.8872

X5=Revenue/Total Assets
=1.651/4.449
=0.3711

The zones of discrimination were as such:

Distress Zones - 1.81 < Grey Zones < 2.99 - Safe Zones

SenesTech has a Altman Z-Score of -43.75 indicating it is in Distress Zones.

Study by Altman found that companies that are in Distress Zone have more than 80% of chances of bankruptcy in two years.


SenesTech  (NAS:SNES) Altman Z-Score Explanation

X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.

X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.

X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.

X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.

X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.

Read more about Altman Z-Score and the original research.


Be Aware

Altman Z-Score does not apply to financial companies.


SenesTech Altman Z-Score Related Terms

Thank you for viewing the detailed overview of SenesTech's Altman Z-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


SenesTech Business Description

Traded in Other Exchanges
N/A
Address
23460 N 19th Avenue, Suite 110, Phoenix, AZ, USA, 85027
SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company provides its solutions to the animal market, commercial markets, and food markets. It currently has two product lines of fertility control products: ContraPest and Evolve.
Executives
Joel Lee Fruendt director, officer: Chief Executive Officer C/O SENESTECH, INC., 23460 N. 19TH AVE., STE 110, PHOENIX AZ 85027
Grandinetti Phillip Nicholas Iii director 23460 N. 19TH AVE SUITE 110, PHOENIX AZ 85027
Kathleen Claire Kavanagh director 23460 N. 19TH AVE SUITE 110, PHOENIX AZ 85027
Jamie Bechtel Morrison director 3140 N. CADEN COURT SUITE 1, FLAGSTAFF AZ 86004
Jacob Steven Leach director 6340 SEQUENCE DRIVE, SAN DIEGO CA 92121
Delphine Francois Chiavarini director 3140 N. CADEN COURT SUITE 1, FLAGSTAFF AZ 86004
Kenneth S Siegel director, officer: Chief Executive Officer 40 STARWOOD HOTELS & RESORTS, 111 WESTCHESTER AVE, WHITE PLAINS NY 10604
Nicole C Williams officer: Chief Strategy Officer 23460 N 19TH AVE SUITE 110, PHOENIX AZ 85027
Steven C. Krause officer: EVP, Sales and Marketing 23460 N. 19TH AVE STE 110, PHOENIX AZ 85027
Loretta Powers Mayer director, 10 percent owner, officer: CEO & Chief Scientific Officer C/O SENESTECH, INC., 3140 N. CADEN COURT, SUITE 1, FLAGSTAFF AZ 86004
Cheryl Ann Dyer director, 10 percent owner, officer: Pres. & Chief Research Officer C/O SENESTECH, INC., 3140 N. CADEN COURT, SUITE 1, FLAGSTAFF AZ 86004
Edward Albe officer: SVP of Commercialization 3140 N. CADEN COURT SUITE 1, FLAGSTAFF AZ 96004
Julia Ann Williams director C/O SENESTECH, INC., 3140 N. CADEN COURT, SUITE 1, FLAGSTAFF AZ 86004
Andrew Altman officer: Chief Operating Officer C/O SENESTECH, INC., 3140 N. CADEN COURT, SUITE 1, FLAGSTAFF AZ 86004
Grover T Wickersham director, officer: Vice Chairman 430 CAMBRIDGE AVENUE, SUITE 100, PALO ALTO CA 94306